00981nas a2200409   4500000000100000008004100001260001300042653001700055653001500072653001000087653001600097653001600113653001100129653001000140653002100150653001100171653001100182653001100193653003000204653001200234653000900246653001900255653002500274653001500299653001600314653000900330653001300339100001600352700001600368700001400384700001400398700001500412245011100427300001200538490000700550022001400557       1971                            d  c1971 May10aAcetanilides10aAdolescent10aAdult10aAge Factors10aBCG Vaccine10aBiopsy10aChild10aChild, Preschool10aFemale10aHumans10aInfant10aInjections, Intramuscular10aleprosy10aMale10aMass Screening10aMycobacterium leprae10aNew Guinea10aSex Factors10aSkin10aSulfones1 aRussell D A1 aShepard C C1 aMcRae D H1 aScott G C1 aVincin D R00aTreatment with 4,4'-diacetyldiaminodiphenylsulfone (DADDS) of leprosy patients in the Karimui, New Guinea.  a495-5010 v20  a0002-9637